Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Shivinder Narwal

Pediatric Gastroenterology Tampa, FL Medical Doctor

NPI 1184619488 CMS profile 880617

3003 W Dr Mlk Blvd, Tampa, FL 33607

Open in the dashboard

General payments

$8,490

288 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Shivinder Narwal of Tampa, FL is reported in the CMS Open Payments database as having received $8,490 across 288 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 88th percentile of Pediatric Gastroenterology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,429 59
2024 General $3,380 73
2023 General $1,205 49
2022 General $761 35
2021 General $862 40
2020 General $169 4
2019 General $684 28

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Shivinder Narwal
  • Pediatric Gastroenterology median
  • Middle half of Pediatric Gastroenterology
  • National median

In program year 2025, general payments to Shivinder Narwal were reported at $1,429. Among 1,132 Pediatric Gastroenterology profiles paid that year, the median was $194 and the middle half received between $81 and $540.

Show as a table
Year Shivinder Narwal Pediatric Gastroenterology median Middle half National median
2019 $684 $131 $41–$311 $163
2020 $169 $79 $23–$223 $114
2021 $862 $104 $32–$321 $132
2022 $761 $125 $37–$331 $149
2023 $1,205 $169 $55–$440 $160
2024 $3,380 $196 $73–$563 $164
2025 $1,429 $194 $81–$540 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Genzyme Corporation $2,018 20 payments
  2. AbbVie, Inc. $1,209 41 payments
  3. VIVUS, Inc. $736 33 payments
  4. Regeneron Healthcare Solutions, Inc. $637 25 payments
  5. Innovative Health Solutions, Inc. $614 6 payments
  6. QOL Medical, LLC $583 28 payments
  7. Nestle HealthCare Nutrition Inc. $483 38 payments
  8. Aimmune Therapeutics, Inc. $466 34 payments
  9. Takeda Pharmaceuticals U.S.A., Inc. $330 14 payments
  10. Evoke Pharma, Inc. $280 5 payments
  11. Other $1,135 44 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $7,297 283 payments
  2. Consulting Fee $1,156 1 payment
  3. Education $37 4 payments
Products named General payments · program years 2019–2025
  1. DUPIXENT Immunology $1,987 19 payments
  2. ZENPEP $875 65 payments
  3. PANCREAZE $736 33 payments
  4. DUPIXENT Inflammation And Immunology $661 20 payments
  5. CREON $415 20 payments
  6. HUMIRA $329 17 payments
  7. GATTEX $294 12 payments
  8. GIMOTI $280 5 payments
  9. Sucraid Therapy For Csid $249 12 payments
  10. Sucraid Therapy For Csid $222 11 payments
  11. Other $1,196 57 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

288 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Pediatric Gastroenterology in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record